Form 8-K - Current report:
SEC Accession No. 0001641172-25-023496
Filing Date
2025-08-13
Accepted
2025-08-13 16:17:38
Documents
15
Period of Report
2025-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41002
2 EX-99.1 ex99-1.htm EX-99.1 168400
3 GRAPHIC form8-k_001.jpg GRAPHIC 19573
4 GRAPHIC ex99-1_001.jpg GRAPHIC 7063
  Complete submission text file 0001641172-25-023496.txt   454396

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE dyai-20250813.xsd EX-101.SCH 3008
6 XBRL LABEL FILE dyai-20250813_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE dyai-20250813_pre.xml EX-101.PRE 22354
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3700
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 251211912
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)